-
Here's What The FDA Approval Of Keytruda Means For Merck, And For Bristol-Myers
Thursday, May 11, 2017 - 11:52am | 347This week, the FDA granted approval for Merck & Co., Inc. (NYSE: MRK)’s Keyruda for chemotherapy combination treatment of frontline lung cancer. While the approval was far from a surprise, it may be enough to move the needle for both Merck and rival Bristol-Myers Squibb Co (NYSE: BMY)....
-
Valeant Expresses Confidence In Outlook, But Might Be Too Early To Get Bullish
Wednesday, May 10, 2017 - 12:09pm | 377The latest chapter in the Valeant Pharmaceuticals Intl Inc (NYSE: VRX) drama is a happy one. Shares of the battered pharma stock are up nearly 24 percent this week after the company reported Q1 earnings and raised its full-year earnings guidance. Despite the good news and the positive move,...
-
A Peek Into The Markets: U.S. Stock Futures Down; All Eyes On Fed Decision
Wednesday, May 3, 2017 - 7:17am | 429Pre-open movers U.S. stock futures traded lower in early pre-market trade. The ADP national employment report for April will be released at 8:15 a.m. ET. US Services Purchasing Managers' Index for April is schedule for release at 9:45 a.m. ET, while the ISM non-manufacturing index for April...
-
Gearing Up For Nvidia's Q1 Earnings: A Technical Take
Monday, May 1, 2017 - 8:44am | 550One of the hottest stocks in the market in recent years, NVIDIA Corporation (NASDAQ: NVDA) has cooled off in the past two months ahead of Q1 earnings expected out on May 9. Nvidia received a double downgrade from Nomura and BMO Capital on February 22 and 23. Since that time, Nvidia has given both...
-
A Peek Into The Markets: U.S. Stock Futures Down Ahead Of International Trade, Factory Orders Data
Tuesday, April 4, 2017 - 7:13am | 418Pre-open movers U.S. stock futures traded lower in early pre-market trade. Data on international trade for February will be released at 8:30 a.m. ET, while data on factory orders for February will be released at 10:00 a.m. ET. Federal Reserve Governor Daniel Tarullo is set to speak in Princeton, N....
-
Oracle's Low Expectations Lead To Well-Received Q3 Results
Thursday, March 16, 2017 - 1:56pm | 415Amid lower expectations, investors cheered Oracle Corporation (NYSE: ORCL)’s third quarter results, which delivered a beat on both consensus revenue and EPS for the first time since November 2014. “Our primary bullish thesis on Oracle is driven by our view that it can grow operating...
-
BMO On Abbott Labs: 'It's Likely Time For The Stock To Take A Pause'
Tuesday, March 14, 2017 - 12:08pm | 408BMO downgrades Abbott Laboratories (NYSE: ABT) to Market Perform from Outperform as shares are trading near the brokerage’s $48 price target. Abbott shares have outperformed year-to-date, increasing 19 percent versus the S&P 500’s 6 percent. BMO views some of this as a “...
-
Why E.L.F. Beauty's Inventory Build In Q4 Is A Good Thing
Thursday, March 9, 2017 - 2:05pm | 396Higher inventory is always considered as a negative for any company, but e.l.f. Beauty Inc (NYSE: ELF)’s heavier than expected inventory at the end of its fourth quarter is good. The cosmetics firm said it was a calculated move to increase supply of its fastest moving items, and should help...
-
FedEx Shares Could Rise Over 30% By 2020
Monday, March 6, 2017 - 12:33pm | 355Fadi Chamoun of BMO Capital upgrades FedEx Corporation (NYSE: FDX) to Outperform and raised price target by $10 to $220. Further, the analyst’s upside case points to a target price of $260 over the medium-term (three years), representing a potential return of 34 percent. What The Margins,...
-
Analyst: Still Looking For Palo Alto Shares To Bottom Out
Wednesday, March 1, 2017 - 3:55pm | 318Markets are reaching new all-time highs, but Palo Alto Networks Inc (NYSE: PANW) isn't reaping any of the benefits. Shares are down 22 percent on following a handful of downgrades following a large third quarter miss. Of the firms that downgraded Palo Alto Networks were William Blair, JP Morgan...
-
What The Sell Side Is Saying About Ramaco Resources
Wednesday, March 1, 2017 - 11:23am | 366Wall Street brokerages started coverage of Ramaco Resources Inc (NASDAQ: METC) on a bullish note, with both Credit Suisse and BMO Capital being Outperform rated on the stock. Ramaco, which began trading in early February, is a metallurgical coal producer. The company is transitioning from...
-
What's Next For Nvidia?
Sunday, February 26, 2017 - 5:24pm | 905It was a rough week for Nvidia Corporation (NASDAQ: NVDA), one of the top performing issues in the S&P 500 index in 2016. Last year, the issue ran up 224 percent from its 2015 year-end close ($32.96) to $106.74. Bad Week Per its 2016 style, the issue began last week with a nearly $4 gain,...
-
As Nvidia Catches A Pair Of Downgrades, Attention Turns To AMD
Thursday, February 23, 2017 - 12:10pm | 360Two of the hottest stocks in the tech sector may have gotten a bit too hot. BMO Capital and Nomura have downgraded NVIDIA Corporation (NASDAQ: NVDA) to Sell and Reduce ratings, respectively. In the past year, NVIDIA shares are up an incredible 604 percent, but the two firms believe the huge move in...
-
For Activision Blizzard, 'Overwatch' And 'Candy Crush' Strength Outweighs 'Call Of Duty' Weakness
Monday, February 13, 2017 - 1:48pm | 411Activision Blizzard, Inc. (NASDAQ: ATVI) crushed earnings expectations for its fourth quarter as "Overwatch" performed better than most anticipated and offset "Call of Duty" weakness. But, BMO Capital’s Gerrick Johnson prefers to remain on sidelines amid elevated investor expectations...
-
How Baseball, 'Deadpool' Drove 21st Century Fox's Q2 Beat; Super Bowl To Add $400 Million Revenue In Q3
Tuesday, February 7, 2017 - 1:25pm | 498BMO Capital maintains its Outperform rating on Twenty-First Century Fox Inc (NASDAQ: FOXA) following its $0.04 EPS beat in its second quarter, driven by the World Series, Fox News ratings and "Deadpool." However, shares were down after the company's total revenue fell short of the Street's view...